EP Patent

EP1446122A1 — Use of flibanserin in the treatment of sexual disorders

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2004-08-18 · 22y expired

What this patent protects

The invention relates to the use of flibanserin for the preparation of a medicament for the treatment of disorders of sexual desire.

USPTO Abstract

The invention relates to the use of flibanserin for the preparation of a medicament for the treatment of disorders of sexual desire.

Drugs covered by this patent

Patent Metadata

Patent number
EP1446122A1
Jurisdiction
EP
Classification
—
Expires
2004-08-18
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.